Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
NCT02723448
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Vasculopathy, Retinal, With Cerebral Leukodystrophy
Cerebroretinal Vasculopathy, Hereditary
Interventions
DRUG:
aclarubicin
Sponsor
Washington University School of Medicine